key findings from phase iia study of primec in als patients
Published 1 year ago • 259 plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
10:55
novel combination therapy primec in als: biomarker data & launch of phase ii trial
-
1:51
phase ii extension trial of cnm-au8 in als
-
2:14
developments in als biomarker research: the all als consortium
-
2:02
categorizing als to improve trial outcomes
-
44:48
the expanding landscape of therapeutic targets in als clinical trials
-
1:00:09
findings from everything als studies
-
26:46
2011, professor orla hardiman, clinical trials in als/mnd: past, present and future
-
19:03
7th annual als one research symposium: day 2 – als industry day: kadimastem.
-
25:42
2021 neuroscience symposium | breaking update: als clinical trials
-
45:00
problems and progress in als clinical trials
-
1:44
unanswered questions in als research
-
40:00
clinical management for als: diagnosis, treatment and clinical trials
-
7:07
said r beydoun, aan 2018 – edaravone in amyotrophic lateral sclerosis (als)
-
14:26
nurown® (autologous msc-ntf cells) in als - phase 3 clinical trial update - ralph kern
-
2:34
matthew b. harms, md: amyotrophic lateral sclerosis updates
-
25:21
webinar: injection of neural stem cells in patients with als: results of a phase i clinical trial
-
2:28
israeli firm develops promising als clinical trials
-
42:10
brainiacs: the unlikely suspect: neurons not responsible for als?
-
2:39
new drug research: tofacitinib & als